leadf
logo-loader
viewBioSig Technologies, Inc.

BioSig Technologies announces completion of PURE EP system at medical center in New Jersey

The system is also undergoing an evaluation and clinical data collection at the center

health
The company also recently added Massachusetts General Hospital and the Hospital of the University of Pennsylvania to its clinical sites

BioSig Technologies Inc (NASDAQ:BSGM) announced Thursday that it has completed the installation of its PURE EP System at the Deborah Heart and Lung Center in Browns Mills, New Jersey. 

In a statement, the company said its PURE EP System is also undergoing an evaluation and clinical data collection at the center, under the leadership of Dr Raffaele Corbisiero. 

“As an innovative and rapidly growing company, we are excited to have physicians at Deborah not only utilize our technology but also contribute to its advancement. Given COVID-19’s detrimental effects on cardiovascular health, this relationship cannot come at a more important time,” said CEO Kenneth Londoner.

READ: BioSig Technologies issues October 2020 Letter to Shareholders providing highlights on the company’s recent developments and updates

Dr Corbisiero added: “Intracardiac signals are the foundation of everything we do in EP, but we can't treat what we don't see. I am impressed by our early experience with PURE EP showing more of the cardiac signals we want to see."

BioSig said it is currently conducting patient cases under the clinical trial titled “Novel Cardiac Signal Processing System for Electrophysiology Procedures (PURE EP 2.0 Study)” at Texas Cardiac Arrhythmia Research Foundation in Austin, Texas and Mayo Clinic Florida Campus in Jacksonville.

The company also recently added Massachusetts General Hospital and the Hospital of the University of Pennsylvania to its clinical sites.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: BioSig Technologies, Inc.

Price: 4.49 USD

NASDAQ:BSGM
Market: NASDAQ
Market Cap: $135.82 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioSig Technologies, Inc. named herein, including the promotion by the Company of BioSig Technologies, Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

BioSig teams up with Sorrento Therapeutics to fight the coronavirus with a...

BioSig Technologies Inc (NASDAQ:BSGM) CEO Kenneth Londoner tells Proactive the group's subsidiary ViralClear Pharmaceuticals, Inc is teaming up with Sorrento Therapeutics, Inc. (NASDAQ: SRNE) to advance the fight against the coronavirus. Londoner says the two biotechs will look at the effective...

on 09/30/2020

2 min read